Association of Exposure to High-risk Antibiotics in Acute Care Hospitals With Multidrug-Resistant Organism Burden in Nursing Homes

Abstract

IMPORTANCELittle is known about the contribution of hospital antibiotic prescribing to multidrugresistant organism (MDRO) burden in nursing homes (NHs). OBJECTIVESTo characterize antibiotic exposures across the NH patient's health care continuum (preceding health care exposure and NH stay) and to investigate whether recent antibiotic exposure is associated with MDRO colonization and room environment contamination at NH study enrollment. DESIGN, SETTING, AND PARTICIPANTS This is a secondary analysis of a prospective cohort study (conducted from 2013-2016) that enrolled NH patients and followed them up for as long as 6 months. The study was conducted in 6 NHs in Michigan among NH patients who were enrolled within 14 days of admission. Clinical metadata abstraction, multi-anatomical site screening, and room environment surveillance for MDROs were conducted at each study visit. Data were analyzed between May 2019 and November 2021. EXPOSURES Antibiotic data were abstracted from NH electronic medical records by trained research staff and characterized by class, route, indication, location of therapy initiation, risk for Clostridioides difficile infection (C diffogenic agents), and 2019 World Health Organization Access, Watch, and Reserve (AWARE) antibiotic stewardship framework categories. MAIN OUTCOMES AND MEASURESThe primary outcomes were MDRO colonization and MDRO room environment contamination at NH study enrollment, measured using standard microbiology methods. Multivariable logistic regression was used to identify whether antibiotic exposure within 60 days was associated with MDRO burden at NH study enrollment. Additionally, antibiotic exposure data were characterized using descriptive statistics. RESULTSA total of 642 patients were included (mean [SD] age, 74.7 [12.2] years; 369 [57.5%] women; 402 [62.6%] White; median [IQR] NH days to enrollment, 6.0 [3.0-7.0]). Of these, 422 (65.7%) received 1191 antibiotic exposures: 368 (57.3%) received 971 hospital-associated prescriptions, and 119 (18.5%) received 198 NH-associated prescriptions. Overall, 283 patients (44.1%) received at least 1 C diffogenic agent, and 322 (50.2%) received at least 1 high-risk WHO AWARE antibiotic (watch or reserve agent). More than half of NH patients (364 [56.7%]) and room environments (437 [68.1%]) had MDRO-positive results at enrollment. In multivariable analysis, recent antibiotic exposure was positively associated with baseline MDRO colonization (odds ratio [

Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study

“…An interesting finding was that antimicrobial exposure in the previous 90 days was associated with decreased odds for death. This is unusual because prior studies have shown that previous antibiotic exposure was associated with acquisition of MDROs, and MDROs have been associated with higher odds of mortality [ 26 , 27 ]. This may be because these patients are in areas with high MDRO exposure and acquired CRPA without traditional risk factors.…”

Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US Hospitals

“…Third, we focused on community-onset sepsis rather than hospital-onset sepsis (where resistant organisms are more prevalent), thus precluding generalizing our findings to all patients with sepsis. We also excluded patients admitted from health care facilities who tend to have higher rates of antibiotic exposure and drug-resistant organisms . Nonetheless, community-onset sepsis accounts for the majority of sepsis cases .…”

Epidemiology of resistant gram-negative bacteria in nursing homes

“…Antibiotics were further dichotomized as high- versus low-risk agents for acquisition of ARO or Clostridioides difficile infection (CDI) based on previously validated metrics. 7 High-risk agents consisted of fluoroquinolones, third–fifth generation cephalosporins, β-lactam/β-lactamase combinations, carbapenems, and lincosamines. Clinical infections (urinary tract infection [UTI], pneumonia, skin soft-tissue infection [SSTI], and CDI) were defined based on diagnosis by the treating physician of record at the nursing home.…”